Description of the trial: The purpose of this clinical trial is to determine whether blood that has been mixed with a solution of saline and hyperbaric levels of dissolved oxygen after successful angioplasty/stenting improves outcomes for heart attack patients compared to standard-of-care treatment.

Population: Patients experiencing persistent chest pain lasting <24 hrs. prior to entry into the cardiac catheterization lab.

Principal Investigator: Hal Skinner, MD

Contact: For more information about the clinical trial contact Jeannie Hamilton, RN, Clinical Research Coordinator, at 859-260-6172 or e-mail jeannie.hamilton@bhsi.com